Bank Of Montreal Vertex Pharmaceuticals Inc Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of Montreal holds 557,217 shares of VRTX stock, worth $226 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

557,217

Previous 511,428 8.95%

Holding current value

$226 Million

Previous $240 Million 8.11%

% of portfolio

0.12%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $21.1 Million - $23.2 Million	45,789 Added 8.95%	557,217 $259 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $1.7 Million - $2.1 Million	4,326 Added 0.85%	511,428 $240 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $27.3 Million - $29.9 Million	-67,025 Reduced 11.67%	507,102 $212 Million
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $17.4 Million - $20.9 Million	50,773 Added 9.7%	574,127 $234 Million
Q3 2023 Nov 01, 2023	BUY	$338.18 - $362.46 $15.4 Million - $16.5 Million	45,439 Added 9.51%	523,354 $182 Million
Q2 2023 Aug 02, 2023	BUY	$314.42 - $351.91 $34.6 Million - $38.7 Million	109,914 Added 29.87%	477,915 $168 Million
Q1 2023 Jun 13, 2024	SELL	$283.23 - $323.1 $19.7 Million - $22.5 Million	-69,664 Reduced 13.74%	437,438 $138 Million
Q4 2022 Feb 01, 2023	BUY	$285.76 - $321.48 $26.4 Million - $29.8 Million	92,547 Added 33.6%	368,001 $106 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $27.6 Million - $30.8 Million	-100,951 Reduced 26.82%	275,454 $81 Million
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $1.16 Million - $1.44 Million	4,932 Added 1.33%	376,405 $106 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $6.55 Million - $7.72 Million	29,599 Added 8.66%	371,473 $96 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $126 Million - $159 Million	-711,485 Reduced 67.54%	341,874 $76.1 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $20.8 Million - $23.2 Million	114,535 Added 12.2%	1,053,359 $192 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $176 Million - $208 Million	938,824 New	938,824 $185 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $104B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account